![Gregor MacRae](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregor MacRae
Corporate Officer/Principal bei
Appledore Wealth Management LLP
Profil
Gregor MacRae is a Senior Partner at Appledore Wealth Management LLP.
He was a Non-Executive Director at OKYO Pharma Ltd. from 2019 to 2020 and at Tiziana Life Sciences Ltd. (United Kingdom) in 2020.
He is a graduate of the University of Birmingham.
Aktive Positionen von Gregor MacRae
| Unternehmen | Position | Beginn |
|---|---|---|
Appledore Wealth Management LLP | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Gregor MacRae
| Unternehmen | Position | Ende |
|---|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Direktor/Vorstandsmitglied | 18.06.2020 |
| WEST AFRICAN MINERALS CORP | Direktor/Vorstandsmitglied | 10.06.2020 |
Ausbildung von Gregor MacRae
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
2
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
OKYO Pharma Ltd.
 OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Health Technology |
Appledore Wealth Management LLP |
